Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesReimbursement/Payment PolicyBCBS Texas Nucleic Acid Test Update | OpenPayer
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield - TexasPolicy RPLAB063

    Identification of Microorganisms Using Nucleic Acid Probes

    Customize your policy alerts

    Sign up for Blue Cross Blue Shield - Texas Policy RPLAB063 alerts

    Get alerted when Policy RPLAB063 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This reimbursement policy governs when nucleic acid identification tests using direct probes, amplified probes, or quantification may be reimbursable or are not reimbursable. It applies to providers submitting laboratory claims to Blue Cross Blue Shield of Texas, subject to applicable plan documents, provider contracts, coding rules, and claim edits.

    Policy Summary
    PayerBlue Cross Blue Shield - Texas
    PolicyIdentification of Microorganisms Using Nucleic Acid Probes
    Policy CodePolicy RPLAB063
    Change TypeMaterial revision
    Effective DateDec 4, 202615d
    Next Review DateN/A
    Key ActionDo not simultaneously order amplified probe and quantification for the same organism in a single encounter.
    SourceLink
    POLICY UPDATE CHANGES

    Pneumocystis jirovecii amplified probe code 87594 and Rubeola virus amplified probe code 87638 were added as may be reimbursable.

    Non-vaginal Candida species and Mycoplasma genitalium, along with their associated codes, were removed from the reimbursement table.

    Direct probe testing for Chlamydia pneumoniae, Cytomegalovirus, Legionella pneumophila, Herpes-virus-6, and Mycoplasma pneumoniae changed from may be reimbursable to not reimbursable.

    The simultaneous-ordering rule was revised to state that ordering amplified probe and quantification tests for the same organism in one encounter is not reimbursable.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    29Procedure codes listed for microorganism nucleic acid testing
    2Newly added potentially reimbursable procedure codes
    3Testing methods addressed
    1Same-encounter ordering restriction

    Microorganism Nucleic Acid Testing Criteria

    Microorganism nucleic acid testing reimbursement criteria

    Reimbursement status for nucleic acid identification is determined by microorganism and procedure type. “MBR” indicates the test may be reimbursable; “INR” indicates the test is not reimbursable. A blank entry means no procedure code is listed in the source table.

    ALL of the following

    • Applicable microorganism and test-specific reimbursement status

      • Bartonella henselae or quintana: Direct probe — no procedure code listed; amplified probe — CPT 87471 (MBR); quantification — CPT 87472 (INR).
      • Chlamydia pneumoniae: Direct probe — CPT 87485 (INR); amplified probe — CPT 87486 (MBR); quantification — CPT 87487 (INR).
      • Clostridium difficile: Direct probe — no procedure code listed; amplified probe — CPT 87493 (MBR); quantification — no procedure code listed.
      • Cytomegalovirus: Direct probe — CPT 87495 (INR); amplified probe — CPT 87496 (MBR); quantification — CPT 87497 (MBR).
      • Enterococcus, vancomycin-resistant (e.g., enterococcus vanA, vanB): Direct probe — no procedure code listed; amplified probe — CPT 87500 (MBR); quantification — no procedure code listed.
      • Enterovirus: Direct probe — no procedure code listed; amplified probe — CPT 87498 (MBR); quantification — no procedure code listed.
      • Hepatitis G: Direct probe — CPT 87525 (INR); amplified probe — CPT 87526 (INR); quantification — CPT 87527 (INR).
      • Herpesvirus-6: Direct probe — CPT 87531 (INR); amplified probe — CPT 87532 (INR); quantification — CPT 87533 (MBR).
      • Legionella pneumophila: Direct probe — CPT 87540 (INR); amplified probe — CPT 87541 (MBR); quantification — CPT 87542 (INR).
      • Mycoplasma pneumoniae: Direct probe — CPT 87580 (INR); amplified probe — CPT 87581 (MBR); quantification — CPT 87582 (INR).
      • Orthopoxvirus: Direct probe — no procedure code listed; amplified probe — CPT 87593 (MBR); quantification — no procedure code listed.
      • Pneumocystis jirovecii: Direct probe — no procedure code listed; amplified probe — CPT 87594 (MBR); quantification — no procedure code listed.
      • Respiratory syncytial virus: Direct probe — no procedure code listed; amplified probe — CPT 87634 (MBR); quantification — no procedure code listed.
      • Rubeola virus: Direct probe — no procedure code listed; amplified probe — CPT 87638 (MBR); quantification — no procedure code listed.
      • Staphylococcus: Direct probe — no procedure code listed; amplified probe — CPT 87640 (MBR); quantification — no procedure code listed.
      • Staphylococcus aureus, methicillin-resistant: Direct probe — no procedure code listed; amplified probe — CPT 87641 (MBR); quantification — no procedure code listed.
    • Simultaneous ordering of any combination of amplified probe and quantification testing for the same organism in a single encounter is not reimbursable.

      Do not bill amplified probe and quantification testing for the same organism together during one encounter.

    Procedure Code Reimbursement Status

    Covered CPT CodesCPTCovered
    87471Bartonella DNA amplified probe
    Not Covered CPT CodesCPTNot Covered
    87472Bartonella DNA quantification
    Not Covered CPT CodesCPTNot Covered
    87485Chlamydia pneumoniae DNA direct probe
    Covered CPT CodesCPTCovered
    87486Chlamydia pneumoniae DNA amplified probe
    Not Covered CPT CodesCPTNot Covered
    87487Chlamydia pneumoniae DNA quantification
    Covered CPT CodesCPTCovered
    87493C. difficile amplified probe
    Not Covered CPT CodesCPTNot Covered
    87495Cytomegalovirus DNA direct probe
    Covered CPT CodesCPTCovered
    87496Cytomegalovirus DNA amplified probe
    87497Cytomegalovirus DNA quantification
    Covered CPT CodesCPTCovered
    87500Vancomycin-resistant Enterococcus DNA amplified probe
    Covered CPT CodesCPTCovered
    87498Enterovirus probe and reverse transcription
    Not Covered CPT CodesCPTNot Covered
    87525Hepatitis G DNA direct probe
    87526Hepatitis G DNA amplified probe
    87527Hepatitis G DNA quantification
    Not Covered CPT CodesCPTNot Covered
    87531HHV-6 DNA direct probe
    87532HHV-6 DNA amplified probe
    Covered CPT CodesCPTCovered
    87533HHV-6 DNA quantification
    Not Covered CPT CodesCPTNot Covered
    87540Legionella pneumophila DNA direct probe
    87542Legionella pneumophila DNA quantification
    Covered CPT CodesCPTCovered
    87541Legionella pneumophila DNA amplified probe
    Not Covered CPT CodesCPTNot Covered
    87580Mycoplasma pneumoniae DNA direct probe
    87582Mycoplasma pneumoniae DNA quantification
    Covered CPT CodesCPTCovered
    87581Mycoplasma pneumoniae DNA amplified probe
    Covered CPT CodesCPTCovered
    87593Orthopoxvirus amplified probe, each
    Covered CPT CodesCPTCovered
    87594Pneumocystis jirovecii amplified probe
    Covered CPT CodesCPTCovered
    87634Respiratory syncytial virus DNA/RNA amplified probe
    Covered CPT CodesCPTCovered
    87638Rubeola virus DNA/RNA amplified probe
    Covered CPT CodesCPTCovered
    87640Staphylococcus aureus DNA amplified probe
    87641Methicillin-resistant Staphylococcus aureus DNA amplified probe

    Claim Submission and Review Requirements

    Documentation Required

    Document services and support claims

    Submit accurate documentation of the services performed with each claim. Upon request, provide any additional documentation supporting the services.

    Billing Rule

    Use valid coding combinations

    Submit claims using valid code combinations from HIPAA-approved code sets and code services appropriately according to applicable industry coding guidelines.

    • Uniform Billing Editor and American Medical Association CPT guidance
    • HCPCS, ICD-10-CM and ICD-10-PCS, and National Drug Codes
    • Diagnosis Related Group guidelines, CMS National Correct Coding Initiative Policy Manual, CCI table edits, and other CMS guidelines

    Reimbursement Status Abbreviations

    Definitions
    MBRMay be reimbursable
    INRNot reimbursable
    Policy Summary
    PayerBlue Cross Blue Shield - Texas
    PolicyIdentification of Microorganisms Using Nucleic Acid Probes
    Policy CodePolicy RPLAB063
    Change TypeMaterial revision
    Effective DateDec 4, 202615d
    Next Review DateN/A
    Key ActionDo not simultaneously order amplified probe and quantification for the same organism in a single encounter.
    SourceLink
    On This Page
    Microorganism Nucleic Acid Testing CriteriaProcedure Code Reimbursement StatusClaim Submission and Review RequirementsReimbursement Status Abbreviations
    Documentation Required

    Verify product-specific requirements

    Review the applicable Plan documents before submitting laboratory claims because reimbursement requirements may differ by product and not all requirements apply to each product.

    • Plan documents govern when they conflict with this reimbursement policy.
    • Eligible coverage for services rendered must be verified under the applicable product.
    Denial Risk

    Expect claim review and edits

    Claims are subject to claim review and code-edit protocols, including review of benefit coverage, provider contract language, medical policies, reimbursement policies, and coding-software logic. Submit supporting documentation when requested.

    • Benefit and contract review
    • Medical-policy and reimbursement-policy review
    • Coding-software logic and claim edits
    Billing Rule

    Avoid simultaneous same-organism testing

    Do not simultaneously order amplified probe and quantification for the same organism in a single encounter. Any such combination is not reimbursable.

    • The restriction applies to any combination of amplified probe and quantification for the same organism.
    • The tests must not be ordered together during one encounter.